Concentrated albumin as a biological glue for hemorrhage control on hepatic resection with argon beam coagulation

Hua Xie, Ronald F. Wolf, Allen P. Burke, Scott B. Gustafson, Kenton Gregory, Scott A. Prahl

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Topically applied concentrated albumin with argon beam coagulation (ABCA) has been shown to be more effective at achieving hemostasis than using argon beam coagulation alone (ABC) in a liver injury model. This study investigated the host response to the concentrated albumin after argon beam coagulation. Complete hemostasis was achieved using ABCA (N = 10) or ABC (N = 10) on a nonanatomic liver resection in a heparinized porcine model. The repairs were evaluated grossly and microscopically at postoperative periods of 30 and 90 days. We found no evidence of biliary leakage, rebleeding, or intraabdominal infection. Blood analysis indicated liver chemistry indices were within normal range after ABC and ABCA treatments. The histopathology showed that the postoperative healing response was similar in both groups: a moderate chronic inflammatory response as part of an on-going normal healing process. All repairs were encapsulated by fibrous tissue. There was no difference in the postsurgical adhesion scores for the ABCA (mean 3.4) and ABC (mean 3.8). It was concluded that use of the concentrated albumin as biological glue in conjunction with argon beam coagulation is a safe and efficient procedure for controlling hepatic hemorrhage in surgery. Further studies are warranted to investigate the clinical significance of this technique.

Original languageEnglish (US)
Pages (from-to)84-89
Number of pages6
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume71
Issue number1
DOIs
StatePublished - Oct 15 2004

Fingerprint

Glues
Argon
Coagulation
Albumins
Liver
Repair
Surgery
Blood
Adhesion
Tissue

Keywords

  • Hemostasis
  • In vivo
  • Liver
  • Wound healing

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Concentrated albumin as a biological glue for hemorrhage control on hepatic resection with argon beam coagulation. / Xie, Hua; Wolf, Ronald F.; Burke, Allen P.; Gustafson, Scott B.; Gregory, Kenton; Prahl, Scott A.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 71, No. 1, 15.10.2004, p. 84-89.

Research output: Contribution to journalArticle

@article{6220d8d79fc741558db9c59ba7a4b7b3,
title = "Concentrated albumin as a biological glue for hemorrhage control on hepatic resection with argon beam coagulation",
abstract = "Topically applied concentrated albumin with argon beam coagulation (ABCA) has been shown to be more effective at achieving hemostasis than using argon beam coagulation alone (ABC) in a liver injury model. This study investigated the host response to the concentrated albumin after argon beam coagulation. Complete hemostasis was achieved using ABCA (N = 10) or ABC (N = 10) on a nonanatomic liver resection in a heparinized porcine model. The repairs were evaluated grossly and microscopically at postoperative periods of 30 and 90 days. We found no evidence of biliary leakage, rebleeding, or intraabdominal infection. Blood analysis indicated liver chemistry indices were within normal range after ABC and ABCA treatments. The histopathology showed that the postoperative healing response was similar in both groups: a moderate chronic inflammatory response as part of an on-going normal healing process. All repairs were encapsulated by fibrous tissue. There was no difference in the postsurgical adhesion scores for the ABCA (mean 3.4) and ABC (mean 3.8). It was concluded that use of the concentrated albumin as biological glue in conjunction with argon beam coagulation is a safe and efficient procedure for controlling hepatic hemorrhage in surgery. Further studies are warranted to investigate the clinical significance of this technique.",
keywords = "Hemostasis, In vivo, Liver, Wound healing",
author = "Hua Xie and Wolf, {Ronald F.} and Burke, {Allen P.} and Gustafson, {Scott B.} and Kenton Gregory and Prahl, {Scott A.}",
year = "2004",
month = "10",
day = "15",
doi = "10.1002/jbm.b.30077",
language = "English (US)",
volume = "71",
pages = "84--89",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "Heterocorporation",
number = "1",

}

TY - JOUR

T1 - Concentrated albumin as a biological glue for hemorrhage control on hepatic resection with argon beam coagulation

AU - Xie, Hua

AU - Wolf, Ronald F.

AU - Burke, Allen P.

AU - Gustafson, Scott B.

AU - Gregory, Kenton

AU - Prahl, Scott A.

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Topically applied concentrated albumin with argon beam coagulation (ABCA) has been shown to be more effective at achieving hemostasis than using argon beam coagulation alone (ABC) in a liver injury model. This study investigated the host response to the concentrated albumin after argon beam coagulation. Complete hemostasis was achieved using ABCA (N = 10) or ABC (N = 10) on a nonanatomic liver resection in a heparinized porcine model. The repairs were evaluated grossly and microscopically at postoperative periods of 30 and 90 days. We found no evidence of biliary leakage, rebleeding, or intraabdominal infection. Blood analysis indicated liver chemistry indices were within normal range after ABC and ABCA treatments. The histopathology showed that the postoperative healing response was similar in both groups: a moderate chronic inflammatory response as part of an on-going normal healing process. All repairs were encapsulated by fibrous tissue. There was no difference in the postsurgical adhesion scores for the ABCA (mean 3.4) and ABC (mean 3.8). It was concluded that use of the concentrated albumin as biological glue in conjunction with argon beam coagulation is a safe and efficient procedure for controlling hepatic hemorrhage in surgery. Further studies are warranted to investigate the clinical significance of this technique.

AB - Topically applied concentrated albumin with argon beam coagulation (ABCA) has been shown to be more effective at achieving hemostasis than using argon beam coagulation alone (ABC) in a liver injury model. This study investigated the host response to the concentrated albumin after argon beam coagulation. Complete hemostasis was achieved using ABCA (N = 10) or ABC (N = 10) on a nonanatomic liver resection in a heparinized porcine model. The repairs were evaluated grossly and microscopically at postoperative periods of 30 and 90 days. We found no evidence of biliary leakage, rebleeding, or intraabdominal infection. Blood analysis indicated liver chemistry indices were within normal range after ABC and ABCA treatments. The histopathology showed that the postoperative healing response was similar in both groups: a moderate chronic inflammatory response as part of an on-going normal healing process. All repairs were encapsulated by fibrous tissue. There was no difference in the postsurgical adhesion scores for the ABCA (mean 3.4) and ABC (mean 3.8). It was concluded that use of the concentrated albumin as biological glue in conjunction with argon beam coagulation is a safe and efficient procedure for controlling hepatic hemorrhage in surgery. Further studies are warranted to investigate the clinical significance of this technique.

KW - Hemostasis

KW - In vivo

KW - Liver

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=4644234882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644234882&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.30077

DO - 10.1002/jbm.b.30077

M3 - Article

VL - 71

SP - 84

EP - 89

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 1

ER -